IRIS
PRETE, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.439
EU - Europa 1.536
AS - Asia 425
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
OC - Oceania 3
AF - Africa 1
Totale 6.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.437
IT - Italia 563
SE - Svezia 402
CN - Cina 347
UA - Ucraina 151
DE - Germania 114
FI - Finlandia 87
GB - Regno Unito 80
FR - Francia 78
IN - India 27
BE - Belgio 19
VN - Vietnam 16
IE - Irlanda 15
JP - Giappone 12
EU - Europa 5
ID - Indonesia 4
NL - Olanda 4
CH - Svizzera 3
ES - Italia 3
HK - Hong Kong 3
IR - Iran 3
KR - Corea 3
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
BR - Brasile 2
MD - Moldavia 2
NO - Norvegia 2
SA - Arabia Saudita 2
SG - Singapore 2
TR - Turchia 2
AL - Albania 1
AZ - Azerbaigian 1
BZ - Belize 1
CA - Canada 1
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
LT - Lituania 1
MA - Marocco 1
ME - Montenegro 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PL - Polonia 1
SY - Repubblica araba siriana 1
Totale 6.413
Salva come PNG Salva come JPEG
Città #
Chandler 609
Fairfield 444
Woodbridge 376
Jacksonville 366
Nyköping 339
Ashburn 307
Houston 303
Ann Arbor 215
Seattle 215
Cambridge 204
Wilmington 193
Bari 162
Lawrence 106
Roxbury 104
Nanjing 98
Beijing 95
New York 92
Des Moines 71
Princeton 49
Inglewood 44
Boardman 38
Marseille 32
Brooklyn 28
Milan 28
Shenyang 27
Nanchang 23
Pune 23
Hebei 22
Paris 20
San Diego 20
Brussels 19
Dearborn 19
Rome 19
Los Angeles 17
Dong Ket 16
Palermo 16
Noicattaro 14
Tianjin 14
Washington 12
London 11
Redwood City 11
Jiaxing 10
Changsha 9
Auburn Hills 8
Dublin 8
Grafing 7
San Mateo 6
Florence 5
Helsinki 5
Kunming 5
Norwalk 5
Ancona 4
Edinburgh 4
Falls Church 4
Hefei 4
Indiana 4
Jinan 4
Ningbo 4
Osaka 4
Padova 4
Rho 4
San Francisco 4
Stimigliano 4
Ardabil 3
Arzano 3
Assèmini 3
Cascina 3
Fuzhou 3
Guangzhou 3
Haikou 3
Incheon 3
Lacchiarella 3
Leawood 3
Lodi 3
Porto Recanati 3
Prescot 3
Reggio Emilia 3
Santa Maria Capua Vetere 3
Tappahannock 3
Verona 3
Waterford 3
Zhengzhou 3
Al Qatif 2
Amsterdam 2
Atlanta 2
Augusta 2
Avezzano 2
Cagliari 2
Camponogara 2
Canosa Di Puglia 2
Casargo 2
Chicago 2
Chisinau 2
Denpasar 2
Gravina In Puglia 2
Grottammare 2
Hangzhou 2
Hong Kong 2
Kilburn 2
Lucca 2
Totale 5.030
Salva come PNG Salva come JPEG
Nome #
L'immunoparesi nel mieloma multiplo 358
null 135
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 118
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 117
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features 115
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 115
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 110
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 105
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 103
Autoantibodies to intracellular antigens: generation and pathogenetic role 101
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 100
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 100
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 99
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 98
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 93
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 92
Vasculitides: Proposal for an integrated nomenclature 89
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 88
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 86
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study. 85
Rheumatic disorders as paraneoplastic syndromes 83
Extra-articular manifestations of rheumatoid arthritis: an update 82
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 81
CD20: A target antigen for immunotherapy of autoimmune diseases 80
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 80
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 79
null 77
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 76
null 76
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 74
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 73
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 70
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 67
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 66
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 61
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 59
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 59
Case series on amyloidosis and organ involvement: a single center experience 58
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 58
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 56
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 54
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 54
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 53
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 52
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma 51
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 51
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 51
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 51
Involvement of FAB subclass-specific determinants in the interaction of human IgG with Streptococcal Protein (PG) 50
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 50
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 49
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 48
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 47
La neutropenia nei pazienti in trattamento: differenziazione dei fattori di crescita 46
Beta-2 microglobulin-free HLA-A class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally toserum FHC expression 46
Monoclonal antibodies (mAb) in the immunotherapy (IT) of autoimmune disease (AD) 44
Clinical use of erythropoietin 44
Vasculiti primarie sistemiche 43
null 42
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 41
Constrictive pericarditis due to AL amyloidosis: a case report. 41
Dosaggio della catena pesante degli antigeni di Istocompatibilita' in pazienti con mieloma multiplo (MM) 39
Analisi molecolare di un anticorpo monoclonale (AcMo) anti-idiotipo “immagine interna” dell’antigene CD4 39
null 39
null 39
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 38
null 38
Immunoparesisi in multiple myeloma 37
null 37
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 37
null 36
Beta 2-microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin's and non-Hodgkin's lymphomas 36
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance 36
Amicrobial pustulosis or erosive pustular dermatosis of the inguinal folds: broad of the same spectrum? 36
null 34
Vasculiti primarie sistemiche 34
Ruolo degli autoanticorpi nelle patologie autoimmuni 33
null 33
null 33
null 33
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 33
Monoclonal antibodies in the immunotherapy of autoimmune diseases 30
Echocardiographic alteration in patients with systemic lupus erythematosus affected by hepatic steatosis: a cross-sectional single center study 30
Serum levels of beta2-microglobulin-free heavy chain of HLA class I antigen are increased in patients with multiple myeloma. Role of FHC size variant 29
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 29
Serum levels of beta2-microglobulin-free heavy chain class I antigen are increased in patients with multiple myeloma. Role of FHC size variants 28
Biomolecular drugs in IBD: news, limits and perspective 28
Functional characterization of peptides mimicking the CD20 epitope recognized by Rituximab 28
Raynaud’s phenomenon: from molecular pathogenesis to therapy 28
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 28
Two structurally different peptides mimic a CD20 epitope recognized by rituximab 27
null 27
Lupus vasculitis: An overview 27
Un esempio di mimotipo per l'iimunoterapia delle patologie autoimmuni 26
null 26
null 26
null 25
null 25
Galectin-3 and Neutrophil-to-Lymphocyte ratio are indicative of heart remodelling and disease severity in patients with Obstructive Sleep Apnoea 24
Dosaggio della catena pesante degli antigeni di istocompatibilità di classe I (HLA-I) nel siero di pazienti con mieloma multiplo 24
Totale 5.965
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019240 0 0 0 0 0 0 0 0 0 0 116 124
2019/20201.344 233 78 32 75 150 115 144 93 151 81 157 35
2020/20211.294 114 30 104 61 191 71 186 109 133 138 97 60
2021/2022816 35 88 6 34 28 66 60 46 39 43 143 228
2022/20231.565 197 207 116 143 171 219 34 181 221 11 46 19
2023/2024619 50 111 38 67 52 182 14 50 23 30 2 0
Totale 6.746